Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Centessa Pharmaceuticals (Nasdaq: CNTA) said members of management will participate in multiple investor conferences in November–December 2025, giving live fireside chats and webcasts. Key events and times:

• Guggenheim Healthcare Innovation — Nov 12, 2025, 10:30 AM ET
• Jefferies Global Healthcare (London) — Nov 18, 2025, 2:00 PM GMT / 9:00 AM ET
• Piper Sandler Healthcare — Dec 2, 2025, 3:00 PM ET
• Evercore Healthcare — Dec 3, 2025, 9:35 AM ET
• Oppenheimer Movers in Rare Disease Summit — Dec 11, 2025

Access live webcasts and archived recordings via the Events and Publications tab on Centessa's investor relations website.

BOSTON and LONDON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences:

Event: Guggenheim 2nd Annual Healthcare Innovation Conference
Date: Wednesday, November 12, 2025
Fireside Chat: 10:30 AM ET

Event: Jefferies Global Healthcare Conference in London
Date: Tuesday, November 18, 2025
Fireside Chat: 2:00 PM GMT/ 9:00 AM ET

Event: 37th Annual Piper Sandler Healthcare Conference
Date: Tuesday, December 2, 2025
Fireside Chat: 3:00 PM ET

Event: 8th Annual Evercore Healthcare Conference
Date: Wednesday, December 3, 2025
Fireside Chat: 9:35 AM ET

Event: Oppenheimer Movers in Rare Disease Summit
Date: Thursday, December 11, 2025

Access to the live webcasts of these events, as well as archived recordings, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/.

About Centessa Pharmaceuticals
Centessa Pharmaceuticals, plc is a clinical-stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines that are transformational for patients. We are pioneering a new class of potential therapies within our orexin receptor 2 (OX2R) agonist program for the treatment of excessive daytime sleepiness (EDS), impaired attention, cognitive deficits, and fatigue and other symptoms across neurological, neurodegenerative and neuropsychiatric disorders. For more information, visit www.centessa.com, which does not form part of this release.

Contact:
Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com

FAQ

When will Centessa Pharmaceuticals (CNTA) present at the Guggenheim Healthcare Innovation Conference?

Centessa's fireside chat is scheduled for Nov 12, 2025 at 10:30 AM ET.

What time is Centessa's Jefferies Global Healthcare Conference presentation in London for CNTA?

The Jefferies fireside chat is on Nov 18, 2025 at 2:00 PM GMT (9:00 AM ET).

Where can investors watch Centessa (CNTA) webcasts and archived presentations from the November–December 2025 conferences?

Live webcasts and archived recordings will be available under the Events and Publications tab on Centessa's investor relations website: https://investors.centessa.com/.

When is Centessa speaking at the Piper Sandler Healthcare Conference for CNTA?

Centessa's fireside chat at Piper Sandler is scheduled for Dec 2, 2025 at 3:00 PM ET.

What date is Centessa appearing at the Evercore Healthcare Conference for CNTA investors?

The Evercore fireside chat is set for Dec 3, 2025 at 9:35 AM ET.

Is Centessa participating in the Oppenheimer Movers in Rare Disease Summit and when for CNTA?

Yes, Centessa will participate in the Oppenheimer Movers in Rare Disease Summit on Dec 11, 2025; webcast access details will be posted on the investor site.